Paper9856463
Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity.
Giger RJ and 5 others. Neuron, 1998. Cited by 315 papers, by iCite.
Cite this record
ConductScience Library. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Papers, record 9856463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9856463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nerve Growth Factors | Major topic |
| Nerve Tissue Proteins | Major topic |
| Receptors, Cell Surface | Major topic |
| Animals | |
| Cells, Cultured | |
| Coculture Techniques | |
| Embryo, Mammalian | |
| Ganglia, Spinal | |
| Ganglia, Sympathetic | |
| Glycoproteins | |
| Humans | |
| Neurons | |
| Neuropilin-1 | |
| Rats | |
| Semaphorin-3A | |
| Superior Cervical Ganglion |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01MH59199 | NIMH NIH HHS | United States | R01MH059199 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9856446 | Dissecting semaphorin signaling. | https://conductscience.org/library/papers/9856446 |
Source PubMed
Cited by113
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 315 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41331253 | A spatial atlas of the complement system uncovers unique expression patterns in postnatal brain development in mice. | Nat Commun | 2025 | https://conductscience.org/library/papers/41331253 | PubMed |
| 40558096 | Rabies virus utilizes neuropilin 2 as an endocytic receptor to trigger TGFBR1-mediated actin polymerization. | J Virol | 2025 | https://conductscience.org/library/papers/40558096 | PubMed |
| 40033046 | Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2. | Sci Rep | 2025 | https://conductscience.org/library/papers/40033046 | PubMed |
| 39099090 | Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/39099090 | PubMed |
| 38750585 | Sex-specific impacts of prenatal bisphenol A exposure on genes associated with cortical development, social behaviors, and autism in the offspring's prefrontal cortex. | Biol Sex Differ | 2024 | https://conductscience.org/library/papers/38750585 | PubMed |
| 38592275 | Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592275 | PubMed |
| 37010951 | Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferases. | Elife | 2023 | https://conductscience.org/library/papers/37010951 | PubMed |
| 35986103 | Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer. | Oncogene | 2022 | https://conductscience.org/library/papers/35986103 | PubMed |
| 35776228 | Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance. | Cancer Metastasis Rev | 2022 | https://conductscience.org/library/papers/35776228 | PubMed |
| 34039996 | Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex. | Nat Commun | 2021 | https://conductscience.org/library/papers/34039996 | PubMed |
| 33640465 | VEGFR1 signaling in retinal angiogenesis and microinflammation. | Prog Retin Eye Res | 2021 | https://conductscience.org/library/papers/33640465 | PubMed |
| 33467517 | Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33467517 | PubMed |
| 33212964 | Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/33212964 | PubMed |
| 32708258 | Emerging Roles for Neuropilin-2 in Cardiovascular Disease. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32708258 | PubMed |
| 31161119 | Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes. | Chonnam Med J | 2019 | https://conductscience.org/library/papers/31161119 | PubMed |
| 30717262 | Neuropilins in the Context of Tumor Vasculature. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30717262 | PubMed |
| 28929539 | Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney. | Dev Dyn | 2017 | https://conductscience.org/library/papers/28929539 | PubMed |
| 28731029 | Nrp2 is sufficient to instruct circuit formation of mitral-cells to mediate odour-induced attractive social responses. | Nat Commun | 2017 | https://conductscience.org/library/papers/28731029 | PubMed |
| 28656251 | Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28656251 | PubMed |
| 28293171 | The Role of Semaphorin 3A in Bone Remodeling. | Front Cell Neurosci | 2017 | https://conductscience.org/library/papers/28293171 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NRP1 | 8829 | PubTator's text mining | https://conductscience.org/library/genes/8829 | NCBI Gene |
| NRP2 | 8828 | PubTator's text mining | https://conductscience.org/library/genes/8828 | NCBI Gene |
| SEMA3A | 10371 | PubTator's text mining | https://conductscience.org/library/genes/10371 | NCBI Gene |
| SEMA3F | 6405 | PubTator's text mining | https://conductscience.org/library/genes/6405 | NCBI Gene |
| SEMA4F | 10505 | PubTator's text mining | https://conductscience.org/library/genes/10505 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9856463
GET https://conductscience.org/api/papers/v1/9856463/cited_by?page=2